Reaction

Gastrointestinal Arteriovenous Malformation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 292 reports · 2 co-occurring drugs

As of the last recalculation, Gastrointestinal Arteriovenous Malformation appears in 292 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE (PRR 25.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dabigatran Etexilate	25	25.0	25.0
Dabigatran Etexilate Mesylate	23	24.4	24.4

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.